Mazur, Robert H. (1974). ”Aspartic acid-based sweeteners”. i George E. Inglett (på engelska). Symposium: sweeteners. Westport, CT: AVI Publishing. sid. 159–63. ISBN 978-0-87055-153-6
Magnuson BA, Burdock GA, Doull J, Kroes RM, Marsh GM, Pariza MW, Spencer PS, Waddell WJ, Walker R, Williams GM (2007). ”Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies”. Critical Reviews in Toxicology 37 (8): sid. 629–727. doi:10.1080/10408440701516184. ISSN1040-8444. PMID 17828671.
Butchko HH, Stargel WW, Comer CP, Mayhew DA, Benninger C, Blackburn GL, de Sonneville LM, Geha RS, Hertelendy Z, Koestner A, Leon AS, Liepa GU, McMartin KE, Mendenhall CL, Munro IC, Novotny EJ, Renwick AG, Schiffman SS, Schomer DL, Shaywitz BA, Spiers PA, Tephly TR, Thomas JA, Trefz FK (april 2002). ”Aspartame: review of safety”. Regulatory Toxicology and Pharmacology 35 (2 Pt 2): sid. S1–93. doi:10.1006/rtph.2002.1542. PMID 12180494.
Marinovich M, Galli CL, Bosetti C, Gallus S, La Vecchia C (oktober 2013). ”Aspartame, low-calorie sweeteners and disease: regulatory safety and epidemiological issues”. Food and Chemical Toxicology 60: sid. 109–15. doi:10.1016/j.fct.2013.07.040. PMID 23891579.
Kirkland D, Gatehouse D (oktober 2015). ”Aspartame: A review of genotoxicity data”. Food and Chemical Toxicology 84: sid. 161–8. doi:10.1016/j.fct.2015.08.021. PMID 26321723.
Panel on Food Additives and Nutrient Sources added to Food (2006). ”Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) related to a new long-term carcinogenicity study on aspartame”. The EFSA Journal 356 (5): sid. 1–44. doi:10.2903/j.efsa.2006.356.
Lajtha A (1994). ”Aspartame consumption: lack of effects on neural function”. The Journal of Nutritional Biochemistry 5 (6): sid. 266–83. doi:10.1016/0955-2863(94)90032-9.
Butchko, HH; Stargel, WW; Comer, CP; Mayhew, DA; Benninger, C; Blackburn, GL; de Sonneville, LM; Geha, RS; et al. (2002). ”Aspartame: review of safety.”. Regulatory Toxicology and Pharmacology 35 (2 Pt 2): sid. S1–93. doi:10.1006/rtph.2002.1542. PMID 12180494.
”"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics Committee on Drugs”. Pediatrics 99 (2): sid. 268–78. februari 1997. doi:10.1542/peds.99.2.268. PMID 9024461.
Magnuson BA, Burdock GA, Doull J, Kroes RM, Marsh GM, Pariza MW, Spencer PS, Waddell WJ, Walker R, Williams GM (2007). ”Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies”. Critical Reviews in Toxicology 37 (8): sid. 629–727. doi:10.1080/10408440701516184. ISSN1040-8444. PMID 17828671.
Butchko HH, Stargel WW, Comer CP, Mayhew DA, Benninger C, Blackburn GL, de Sonneville LM, Geha RS, Hertelendy Z, Koestner A, Leon AS, Liepa GU, McMartin KE, Mendenhall CL, Munro IC, Novotny EJ, Renwick AG, Schiffman SS, Schomer DL, Shaywitz BA, Spiers PA, Tephly TR, Thomas JA, Trefz FK (april 2002). ”Aspartame: review of safety”. Regulatory Toxicology and Pharmacology 35 (2 Pt 2): sid. S1–93. doi:10.1006/rtph.2002.1542. PMID 12180494.
Marinovich M, Galli CL, Bosetti C, Gallus S, La Vecchia C (oktober 2013). ”Aspartame, low-calorie sweeteners and disease: regulatory safety and epidemiological issues”. Food and Chemical Toxicology 60: sid. 109–15. doi:10.1016/j.fct.2013.07.040. PMID 23891579.
Kirkland D, Gatehouse D (oktober 2015). ”Aspartame: A review of genotoxicity data”. Food and Chemical Toxicology 84: sid. 161–8. doi:10.1016/j.fct.2015.08.021. PMID 26321723.
Butchko, HH; Stargel, WW; Comer, CP; Mayhew, DA; Benninger, C; Blackburn, GL; de Sonneville, LM; Geha, RS; et al. (2002). ”Aspartame: review of safety.”. Regulatory Toxicology and Pharmacology 35 (2 Pt 2): sid. S1–93. doi:10.1006/rtph.2002.1542. PMID 12180494.
”"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics Committee on Drugs”. Pediatrics 99 (2): sid. 268–78. februari 1997. doi:10.1542/peds.99.2.268. PMID 9024461.